What question did this study set out to answer?

Evaluate associations between functional status, clinical risk, and treatment feasibility in DLBCL patients.

March 5, 2026

Diffuse large B-cell lymphoma outcomes in an urban safety-net cohort: functional status, clinical risk, and treatment feasibility.

View Full Paper

Ask AI

Bookmark

Evaluate associations between functional status, clinical risk, and treatment feasibility in DLBCL patients.
Conducted a retrospective cohort study of patients with newly diagnosed DLBCL treated at an urban safety-net hospital.
Analyzed patient demographics and clinical factors such as insurance status and HIV status.
Calculated overall survival rates and examined associations with functional status and clinical risk stratification.
Estimated one-year overall survival was 62%, with significant risk factors identified.
Eastern Cooperative Oncology Group performance status ≥2 associated with a hazard ratio of 2.45 for inferior survival.
Higher revised International Prognostic Index score linked to increased risk of poor outcomes.

No takes yet. Share an insight, caveat, or question.

Cohort study examines survival related to functional status and treatment in urban DLBCL patients, suggesting important implications for care.

Thida et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Cohort study examines survival related to functional status and treatment in urban DLBCL patients, suggesting important implications for care.